Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,456 | 21,952 | 20,723 | 21,179 | 20,612 |
| Receivables | 7,525 | 10,694 | 11,194 | 11,511 | 12,497 |
| Inventories | 9,058 | 9,534 | 8,902 | 8,925 | 10,630 |
| Other current assets | 0 | 2 | 3,555 | 0 | 0 |
| TOTAL | $35,400 | $44,095 | $44,374 | $43,751 | $45,911 |
| Non-Current Assets | |||||
| PPE Net | 997 | 965 | 1,127 | 1,569 | 1,384 |
| Intangibles | 122,122 | 162,344 | 195,018 | 229,181 | 253,404 |
| Other Non-Current Assets | 1,385 | 1,656 | 1,133 | 1,404 | 3,207 |
| TOTAL | $124,504 | $164,965 | $197,278 | $232,154 | $257,995 |
| Total Assets | $159,904 | $209,060 | $241,652 | $275,905 | $303,906 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,828 | 4,692 | 13,056 | 12,000 | 9,750 |
| Accounts payable and accrued liabilities | 8,709 | 14,107 | 11,591 | 9,316 | 14,223 |
| Other current liabilities | 33 | 1,720 | 1,887 | 901 | 6,216 |
| TOTAL | $22,545 | $26,688 | $31,190 | $27,672 | $35,642 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60,740 | 82,045 | 83,279 | 84,134 | 96,205 |
| Other Non-Current Liabilities | 778 | 1,768 | 817 | 1,884 | 2,034 |
| TOTAL | $66,018 | $84,675 | $85,144 | $87,497 | $99,015 |
| Total Liabilities | $88,563 | $111,363 | $116,334 | $115,169 | $134,657 |
| Shareholders' Equity | |||||
| Common Shares | 260,595 | 262,127 | 265,206 | 265,917 | 257,411 |
| Retained earnings | -194,180 | -175,457 | -148,449 | -119,857 | -101,575 |
| Other shareholders' equity | -10,210 | -2,838 | -5,260 | 2,959 | 2,020 |
| TOTAL | $71,341 | $97,697 | $125,318 | $160,736 | $169,249 |
| Total Liabilities And Equity | $159,904 | $209,060 | $241,652 | $275,905 | $303,906 |